CLINICAL_TRIALS
trial_result
· 2011-05-12
Clinical Trial Update: A Comparison of Once a Day Dose Compared to 2 Doses/Day [Phase 3]
Summary
Phase 3 trial comparing once-daily dosing to twice-daily dosing of mesalamine for ulcerative colitis; results completed and posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Warner Chilcott | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2011-05-12